Baermed Liver Cell Technologies

Baermed Liver Cell Technologies is a Swiss biotechnology company specializing in regenerative medicine and advanced cell therapies for the treatment of severe liver diseases. Founded by Professor Hans-Ullrich Baer, the company has developed a proprietary autologous liver cell transplantation (ALCT) technique designed to restore liver function and stimulate organ regeneration. The process involves harvesting a small portion of the patient's own liver tissue, isolating healthy hepatocytes, and re-infusing them into the portal vein. This approach aims to provide a viable alternative to traditional liver transplantation for patients suffering from cirrhosis or liver failure. Baermed operates primarily out of Zurich, integrating specialized abdominal surgery with innovative biotechnological applications.